Pharmafile Logo

Consumer health specialist joins Research Partnership Inc

Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia.

Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia. Jennifer is a seasoned market research professional with extensive experience in both custom research and marketing consultation. She has 20+ years’ experience on the supplier side with a primary focus on Consumer Healthcare and CPG. Though adept at qualitative research, Jennifer has particular expertise and interest in quantitative research and analysis.

Previously Jennifer has held senior positions at Healogix, AMC Global and GfK/Arbor. A few of her long-term clients include Sanofi CHC, Coca-Cola, and P&G.

Sabera Hyderally said of her appointment, “I am delighted to welcome Jen to the company. We have a dynamic group of researchers in the Philadelphia office and Jen’s consumer experience adds another layer of expertise within the group.”

Speaking about the appointment, Founding Director Mary Assimakopoulos said, “We are very pleased that Jennifer has chosen to join Research Partnership. The US has seen considerable growth under Sabera’s leadership and Jennifer’s appointment further cements the strength of our senior team.”

Visit researchpartnership.com to find out more.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

AI in the clinic: How AI is reshaping clinical behavior

AI is becoming an increasingly important part of clinical practice, moving beyond administrative tasks to influence how physicians access information and make treatment decisions.

Oncology innovation: The human cost of keeping pace with advances in cancer care

New research from Inizio Evoke explores the growing complexity of oncology innovation and how pharmaceutical companies can better support healthcare professionals (HCPs).

AI-enabled biotech commercialization for a successful US therapy launch with Tonix

Inizio helped Tonix successfully launch the first FDA-approved therapy in its class in almost two decades by delivering an integrated, AI-enabled commercialization program spanning analytics, field operations, and launch readiness.

How pharma companies can use AI to scale personalized engagement without increasing complexity

AI is creating a world of opportunities for pharma companies to deliver more personalized HCP and patient engagement. But realizing the full potential of AI takes more than just introducing…

Creating the conditions for product launch success in a time of volatility

Volatility is reshaping the conditions for successful product launches. Market dynamics can shift quickly, assumptions can change, and teams are increasingly expected to make confident decisions in response.

Navigating uncertainty in life sciences

The life sciences industry is changing fast. Advances in AI, increasingly complex science, shifting market dynamics and evolving patient needs are creating new challenges for organizations developing and commercializing treatments….

Inizio appoints Oisín Ó Gógáin as Chief People Officer

Inizio has appointed Oisín Ó Gógáin as Chief People Officer.

Pharma leadership strategies for talent, AI adoption, and continuous learning

In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership can support talent development, use AI to augment the workforce, encourage continuous…

Smarter science, sharper strategy: Expert insights from ASCO® 2026

As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

Intelligent Commercialization™ across the pharma lifecycle

Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.